Supreme Court takes on Pur­due Phar­ma bank­rupt­cy case

Last year
Pharma
Law

Gilead agrees to pay $247M to set­tle HIV drug case that al­leged com­pe­ti­tion block­ing

Last year
Pharma
Law

No­vo Nordisk buck­les down on lob­by­ing ef­forts, inch­ing to­ward CMS cov­er­age of obe­si­ty treat­ments

Last year
Pharma
FDA+

Last re­sort: On­copep­tides for­mal­ly chal­lenges FDA's with­draw­al of can­cer drug's ac­cel­er­at­ed ap­proval

Last year
FDA+

Bris­tol My­ers de­buts cor­po­rate brand ‘an­them’ film on dig­i­tal and so­cial chan­nels, cel­e­brat­ing its sci­ence and ...

Last year
Pharma
Marketing

PhRMA urges court to stop gov­ern­ment drug price ne­go­ti­a­tions be­fore they start

Last year
Law

Phar­ma com­pa­nies look to tap med­ical so­cial in­flu­encers in new agency part­ner­ship

Last year
R&D
Marketing

Drug­mak­ers pull back af­ter Covid boom, plan­ning to cut costs as they pre­pare for in­dus­try’s next era

Last year
R&D
Pharma

ALX cuts two an­ti-CD47 pro­grams just weeks af­ter Gilead stopped a piv­otal study of its own can­di­date

Last year
R&D

New Alzheimer’s drug rais­es hopes — along with ques­tions

Last year
R&D

Ake­bia no­ti­fies SEC it will be late fil­ing Q2 earn­ings; Sur­rozen cuts two ear­ly pro­grams

Last year
News Briefing

Hen­ri­et­ta Lack­s' fam­i­ly sues Ul­tragenyx over use of im­mor­tal HeLa cell line, claim­ing un­just en­rich­ment

Last year
R&D
Law

Atre­ca holds off de­vel­op­ment on its on­ly clin­i­cal pro­gram, cuts head­count by 40%

Last year
People
R&D

Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

Last year
Peer Review

Up­dat­ed: Il­lu­mi­na's $7.1B Grail deal be­ing in­ves­ti­gat­ed by SEC

Last year
Pharma

En­do sues Zy­dus in patent bat­tle over meth­ods of pu­ri­fy­ing gener­ic ver­sion of re­called smok­ing ces­sa­tion drug Chan­tix

Last year
Pharma
Law

Drug price in­creas­es lay­ered over decades: AARP analy­sis shows how list prices can rise by more than 700%

Last year
Pharma
Law

As­traZeneca, PhRMA sue Louisiana in fed­er­al court over state 340B drug ac­cess law

Last year
Pharma
Law

RSV mar­ket­ing bat­tle shap­ing up with GSK and Pfiz­er cam­paigns run­ning on TV, dig­i­tal chan­nels ahead of the vi­ral ...

Last year
Pharma
Marketing

FDA lays out post­mar­ket­ing ap­proach­es for da­ta col­lec­tion from un­der­rep­re­sent­ed groups

Last year
Pharma
FDA+

Man­u­fac­tur­ing roundup: AGC Bi­o­log­ics opens new fa­cil­i­ty in Mi­lan; Charles Riv­er drops Q2 num­bers

Last year
Manufacturing

Sen­ti Bio of­floads man­u­fac­tur­ing site to Hong Kong PE firm for $38M

Last year
Deals
Manufacturing

No­vo Nordisk an­tic­i­pates patchy We­govy sup­ply in the com­ing months as it pro­vides in­sight on man­u­fac­tur­ing plans

Last year
Pharma
Manufacturing

HIV cell ther­a­py biotech Ad­dim­mune to go pub­lic via SPAC merg­er; WHO names new Covid-19 'vari­ant of in­ter­est'

Last year
News Briefing
First page Previous page 297298299300301302303 Next page Last page
A service from the Financial Times